Skip to main content
. 2021 Jan 4;6(1):100029. doi: 10.1016/j.esmoop.2020.100029

Figure 3.

Figure 3

Overall survival in metastatic patients according to IHC subtypes.

HER2, human epidermal growth factor receptor 2; HR, hormone receptor; IHC, immunohistochemistry; TNBC, triple-negative breast cancer.